Data Foundry

Medical device recalls 2025

HemosIL LMW Heparin Controls — Class II medical device recall Z-2323-2025

Ongoing recall by Instrumentation Laboratory, reported 2025-08-20, distributed nationwide. Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recov

Recall numberZ-2323-2025
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmInstrumentation Laboratory, Bedford, MA, United States
Recall initiated2025-02-03
Classified2025-08-13
Reported by FDA2025-08-20
DistributedNationwide (US)
Countries outside the USAR, AT, AU, BG, BR, CA, CH, CL, CN, CO, CR, CZ, DE, DK, DZ, ES, FI, GB, GR, GT, HK, HU, IE, IL, IN, IT, JP, KR, KW, LB, LT, MX, MY, PA, PE, PL, PT, PY, QA, RO, RS, RU, SA, SE, TH, TN, TR, UY, VN, ZA
Quantity41,824 units
UPC / GTIN / UDI-DI08426950472490
Lot numbersN0148986, N0330228, N0441476, N0632773, N0643673, N0845161, N0935135, N1036592, N1147397
Model numbers0020300200

Product

HemosIL LMW Heparin Controls; Part Number: 0020300200;

Reason for recall

Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL Liquid Anti-Xa and HemosIL Heparin Calibrator. In some complaints, failure to pass QC resulted in patient testing delays.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2323-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.